Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease

MCG Stevens, N Bouvet, C Ellershaw, F Flamant, JL Habrand, HB Marsden, H Martelli, O Oberlin, A Rey, J Sanchez de Toledo, RD Spicer, D Spooner, MJ Terrier-Lacombe, A Van Unnik

Research output: Contribution to journalArticle (Academic Journal)

24 Citations (Scopus)
Translated title of the contributionRevisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease
Original languageEnglish
Pages (from-to)427 - 431
Number of pages5
JournalEuropean Journal of Cancer
Volume44
Publication statusPublished - 2008

Bibliographical note

Publisher: Elsevier
Other: Key Words: Doxorubicin, Rhabdomyosarcoma, Children

Cite this

Stevens, MCG., Bouvet, N., Ellershaw, C., Flamant, F., Habrand, JL., Marsden, HB., Martelli, H., Oberlin, O., Rey, A., Sanchez de Toledo, J., Spicer, RD., Spooner, D., Terrier-Lacombe, MJ., & Van Unnik, A. (2008). Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: An up-front window study in newly diagnosed children with high-risk metastatic disease. European Journal of Cancer, 44, 427 - 431.